Published: Feb 2017
ACE Report #10354
Ace Report Cover Cannabis

Tetrahydrocannabinol similar in efficacy & safety as placebo in improving spasticity and pain in MS

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Effects on Spasticity and Neuropathic Pain of an Oral Formulation of delta9-Tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis

Clin Ther. 2018 Sep;40(9):1467-1482. doi: 10.1016/j.clinthera.2017.01.016

Contributing Authors: G van Amerongen K Kanhai AC Baakman J Heuberger E Klaassen TL Beumer RLM Strijers J Killestein J van Gerven A Cohen GJ Groeneveld

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.